GCP
ZYME icon

GSA Capital Partners’s Zymeworks ZYME Stock Holding History

GSA Capital Partners’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,511
Closed -$514K – 2233
2026
Q1 		$514K Buy
+20,511
New +$485K 0.03% 901
2023
Q2 		– Sell
-37,093
Closed -$335K – 2004
2023
Q1 		$335K Buy
37,093
+9,230
+33% +$80.5K 0.03% 958
2022
Q4 		$219K Buy
+27,863
New +$196K 0.03% 1132
2022
Q2 		– Sell
-46,149
Closed -$302K – 1868
2022
Q1 		$302K Buy
46,149
+31,652
+218% +$282K 0.04% 886
2021
Q4 		$238K Sell
14,497
-35,504
-71% -$740K 0.03% 1101
2021
Q3 		$1.45M Buy
+50,001
New +$1.66M 0.15% 139

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

GSA Capital Partners's ZYME Position: Q2 2026 in Review

GSA Capital Partners sold out of Zymeworks (ZYME) in Q2 2026, closing a stake of 20,511 shares — an estimated $514K sold.

GSA Capital Partners first reported a position in ZYME in Q3 2021 and held it in 6 quarters. The position peaked at $1.45M in Q3 2021. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • GSA Capital Partners reported no remaining Zymeworks position as of Q2 2026 after selling out during the quarter.
  • GSA Capital Partners sold 20,511 Zymeworks shares in Q2 2026, an estimated $514K.
  • GSA Capital Partners first reported a position in Zymeworks in Q3 2021 and held it in 6 quarters.
  • GSA Capital Partners's Zymeworks position peaked at $1.45M in Q3 2021.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.